JOHN W CHILDS

CIK 1027035 · Chairman & CEO · last filed 2026-03-09

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$118.67M

Companies

4

Total Filings

64

Lifetime Open-Market Net

$10.32M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
BHVN Director 8,015,222 $11.28 $90.41M $137.15M 39 2026-03-09
MANE Director 294,117 $96.07 $28.26M $10.00M 2 2026-02-27
Biohaven Pharmaceutical Holding Co Ltd. (BHVNw) Delisted Director 0 $0 1 2022-10-03
MATTRESS FIRM HOLDING CORP. (MFRM) Delisted Director 440,239 -$136.83M 4 2016-02-10

Recent Filings · Page 3 of 7

64 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2023-05-04 BHVN Grant (A) $0 EDGAR
2023-03-22 BHVN Buy (P) +3,709,819 $38.95M EDGAR
2022-10-26 BHVN Buy (P) +3,900,000 $40.95M EDGAR
2022-10-05 Other (J) +1,517,500 $0
2022-10-05 Mixed +1,522,110 -$14
2022-10-05 Buy (P) +274,141 $2.46M
2022-10-03 Biohaven Pharmaceutical Holding Co Ltd. (BHVNw) Delisted Disp (D) −3,035,001 -$450.70M EDGAR
2022-04-29 BHVN Grant (A) $0 EDGAR
2021-11-17 BHVN Exer (M) +474,200 $4.01M EDGAR
2021-11-10 BHVN Buy (P) +5,000 $614.3K EDGAR
Showing 2130 of 64
Page 3 of 7
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.